1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NUDT3 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA TSSK6 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA FCER1G CTRPv2 pan-cancer AAC 0.11 0.002
mRNA ZNF223 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA KAT6A CTRPv2 pan-cancer AAC 0.11 0.002
mRNA AC003005.4 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA IRF2BP1 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA ATAD2B CTRPv2 pan-cancer AAC 0.12 0.002
mRNA LNPK CTRPv2 pan-cancer AAC 0.11 0.002
mRNA C1QA CTRPv2 pan-cancer AAC 0.1 0.002
Download CSV